EmeTerm is a safe and effective anti-nausea wristband that prevents and relieves nausea and vomiting induced by motion sickness (while in a car, a boat, or a plane) and morning sickness (during pregnancy).
Location: Canada, British Columbia, Vancouver
Phone: +1 805-852-6820
Mentions in press and media 20
| Date | Title | Description |
| 17.08.2026 | U.S. Recruitment for Ohio State University Study Evaluating EmeTerm in Adults With Chronic Nausea and Vomiting | VANCOUVER, BC, Aug. 17, 2026 /PRNewswire/ -- Participant recruitment information for a clinical study being conducted at The Ohio State University has been publicly posted on ClinicalTrials.gov. The study, titled "Evaluating the Effect... |
| 10.02.2026 | WAT Medical's EmeTerm Wearable Device Demonstrates Superior Control of Moderate to Severe Postoperative Nausea and Vomiting in JAMA Surgery-Published Clinical Trial | VANCOUVER, BC, Feb. 10, 2026 /PRNewswire/ -- WAT Medical is proud to announce the publication of a landmark randomized clinical trial in JAMA Surgery, one of the world's most reputable and high-impact surgical journals. The study confirms t... |
| 03.11.2025 | EmeTerm Wristband Significantly Reduces Postoperative Nausea and Vomiting in Major Orthopedic Surgeries | VANCOUVER, BC, Nov. 3, 2025 /PRNewswire/ -- WAT Medical Enterprise Ltd. proudly announced the publication of a groundbreaking clinical trial in The Journal of Bone & Joint Surgery (JBJS) which demonstrates the significant benefits of th... |
| 15.09.2025 | EmeTerm Wearable Device Under Clinical Study at Ohio State Wexner Medical Center Shows Promise for Chronic Nausea Patients | VANCOUVER, BC, Sept. 15, 2025 /PRNewswire/ -- WAT Medical Enterprise Ltd. is proud to announce that its innovative anti-nausea wristband, EmeTerm, has made significant progress in alleviating nausea and vomiting among patients suffering fro... |
| 16.06.2025 | American Migraine Foundation Highlights HeadaTerm2 in Its Latest Device Recommendations, Backed by Clinical Evidence | VANCOUVER, BC, June 16, 2025 /PRNewswire/ -- WAT Medical Enterprise Ltd. is pleased to announce that its migraine relief device, HeadaTerm 2, is now featured on the American Migraine Foundation's (AMF) updated Device Corner, a patient educa... |
| 13.01.2025 | Neuromodulation Wristband ObeEnd Reduces Heart Rate and Perceived Exercise Exertion | VANCOUVER, BC, Jan. 13, 2025 /PRNewswire/ -- WAT Medical Enterprise collaborated with Concordia University and Mitacs Canada to conduct a study using ObeEnd, the neuromodulation device designed by WAT for weight and health management. The s... |
| 09.12.2024 | WAT Medical Sponsors American Headache Society 2024 Scottsdale Headache Symposium | VANCOUVER, BC, Dec. 9, 2024 /PRNewswire/ -- WAT Medical Enterprise proudly sponsored the 2024 Scottsdale Headache Symposium, organized by the American Headache Society from November 14-17 in Scottsdale, AZ. This annual event brought togethe... |
| 18.11.2024 | WAT Medical Continues Support for Red Cross and Veterans Association | VANCOUVER, BC, Nov. 18, 2024 /PRNewswire/ -- WAT Medical Enterprise Ltd. proudly reaffirms its commitment to community support by donating to the American Red Cross and the American Veterans Association. These donations are part of the comp... |
| 16.10.2024 | EmeTerm Smart and HeadaTerm 2 Achieve Health Canada MDL Certification | VANCOUVER, BC, Oct. 16, 2024 /PRNewswire/ -- WAT Medical Enterprise proudly announces a significant achievement: both EmeTerm Smart and HeadaTerm 2 have received Medical Device Licences (MDL) from Health Canada. EmeTerm Smart was certified ... |
| 08.08.2024 | Innovative Anti-Nausea Smartwatch EmeTerm® Smart Set to Launch on Indiegogo | VANCOUVER, BC, Aug. 8, 2024 /PRNewswire/ -- EmeTerm® Smart uses patented hybrid technology to seamlessly integrate the functionality of a smartwatch with that of an anti-nausea wristband, ensuring a carefree and healthy life for all. EmeTer... |
Show more